Over the past decade, the clinical utility of monoclonal antibodies has been realized and
antibodies are now a mainstay for the treatment of cancer. Antibodies have the unique …

This article summarizes recommendations reached following a systematic literature review
and expert consensus on the diagnosis and management of cutaneous squamous cell …

Despite recent advances in radiotherapy, a majority of patients diagnosed with pancreatic
cancer (PC) do not achieve objective responses due to the existence of intrinsic and …

One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …

Abstract Learning Objectives Compare survival outcomes among patients with SCCHN
treated with a platinum/5‐FU regimen with and without cetuximab. Compare adverse event …

OBJECTIVE: Photodynamic therapy (PDT) is used in curative and palliative treatment of
head and neck squamous cell carcinoma (HNSCC). To evaluate available evidence on the …

Background Recently it has been shown that radiation induces migration of glioma cells and
facilitates a further spread of tumor cells locally and systemically. The aim of this study was …

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab
target the human epidermal growth factor receptor and have been integrated into treatment …

Squamous cell carcinoma of the head and neck (SCCHN) is a difficult to treat malignancy
and represents the seventh most common cancer worldwide. Systemic therapy has a critical …

Recent advances in understanding the tumor's biology in line with a constantly growing
number of innovative technologies have prompted characterization of patients' individual …